Ledger.Open graph →
SEC Form D · Amendment · filed September 16, 2016

Sound Pharmaceuticals Inc

Offering
$5.0M
Sold
$4.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Eric Lynch · Seattle, WAExec · DirectorHunt Stookey · Hingham, MAExec · DirectorGlenn Kawasaki · Seattle, WADirectorJames P. Rickey · Seattle, WAExecJonathan Kil · Seattle, WAExec · DirectorJoseph Ashley · Seattle, WADirectorGregory H. Ekizian · New York, NYExec · DirectorGlenn Kawasaki · Seattle, WADirectorJames P. Rickey · Seattle, WAExecJonathan Kil · Seattle, WAExec · DirectorJoseph Ashley · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗